The Carlyle Group Inc. - Common Stock (CG)

U.S. stocks traded mixed at midday Wednesday, as investors remained cautious ahead of the Federal Reserve’s upcoming policy decision, with Chair Jerome Powell set to speak at 2:30 p.m. ET.

Bill Miller IV‘s investment firm has seen significant losses in its fourth-quarter portfolio additions as market uncertainties persist.

This is the third big AI move the bank has made this year.

SoftBank has acquired Oracle-backed Ampere for $6.5 billion to strengthen its AI infrastructure strategy in the U.S., marking a major step in its broader push into Arm-based computing and large-scale AI development.

Analysts expect rebound in M&A and financing activity, but uncertainties may pause it. Estimates slashed for GS and JEF, CG downgraded to Perform.

When uncertainty spikes, our ability to look out into the future shrinks.

Bristol Myers Squibb to acquire 2seventy Bio for $5.00 per share in a $286 million all-cash deal, an 88% premium to its last close. Expected to close in Q2 2025.

bluebird bio agrees to be acquired by Carlyle Group and SK Capital, offering stockholders up to $9.84 per share in a strategic buyout.

The company’s fee-earning assets under management (AUM) fell by 1% to $304 billion compared with last year.

Goldman Sachs predicts winners and losers among alternative asset managers, brokers, and traditional managers in 2025, with bold rating adjustments.

U.S.